Literature DB >> 16398535

Physiochemical properties of low and high molecular weight poly(ethylene glycol)-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides.

Martin Glodde1, Shashank R Sirsi, Gordon J Lutz.   

Abstract

Inefficient delivery of antisense oligonucleotides (AOs) to target cell nuclei remains as the foremost limitation to their usefulness. Copolymers of cationic poly(ethylene imine) (PEI) and poly(ethylene glycol) (PEG) have been well-studied for delivery of plasmids. However, the properties of PEG-PEI-AO polyplexes have not been comprehensively investigated. Therefore, we synthesized a series of PEG-PEI copolymers and evaluated their physiochemical properties alone and when complexed with AO. The M(w) of PEG was found to be the main determinant of polyplex size, via its influence on particle aggregation. DLS measurements showed that when PEG5000 was grafted to PEI2K and PEI25K, polyplex diameters were extremely small (range 10-90 nm) with minimal aggregation. In contrast, when PEG550 was grafted to PEI2K and PEI25K, polyplexes appeared as much larger aggregates (approximately 250 nm). As expected, the surface charge (zeta potential) was higher for polyplexes containing PEI25K than those containing PEI2K, but decreased with increased levels of PEG grafting. Surprisingly, within the physiological range (pH 7.5-5), the buffering capacity of all copolymers was nearly equivalent to that of unsubstituted PEI2K or PEI25K, and was barely influenced by PEGylation. The stability of polyplexes was evaluated using a heparin polyanion competition assay. Unexpectedly, polyplexes containing PEI2K showed stability equal to or greater than that of PEI25K polyplexes. The level of PEG grafting also had a dramatic effect on polyplex stability. The relationships established between molecular formulations and polyplex size, aggregation, surface charge, and stability should provide a useful guide for future studies aimed at optimizing polymer-mediated AO delivery in cell and animal studies. A summary of the relationships between polyplex structures and recent studies of their transfection capacity is provided.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16398535     DOI: 10.1021/bm050726t

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  22 in total

1.  Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors.

Authors:  Shashank R Sirsi; Sonia L Hernandez; Lukasz Zielinski; Henning Blomback; Adel Koubaa; Milo Synder; Shunichi Homma; Jessica J Kandel; Darrell J Yamashiro; Mark A Borden
Journal:  J Control Release       Date:  2011-09-17       Impact factor: 9.776

Review 2.  Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?

Authors:  Pascale R Leroueil; Seungpyo Hong; Almut Mecke; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  Acc Chem Res       Date:  2007-05-03       Impact factor: 22.384

3.  The effect of N/P ratio on the in vitro and in vivo interaction properties of PEGylated poly[2-(dimethylamino)ethyl methacrylate]-based siRNA complexes.

Authors:  Dana J Gary; Jungbin Min; Youngwook Kim; Keunchil Park; You-Yeon Won
Journal:  Macromol Biosci       Date:  2013-07-05       Impact factor: 4.979

4.  Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes.

Authors:  Dana J Gary; Hoyoung Lee; Rahul Sharma; Jae-Sung Lee; Youngwook Kim; Zheng Yun Cui; Di Jia; Valorie D Bowman; Paul R Chipman; Lei Wan; Yi Zou; Guangzhao Mao; Keunchil Park; Brittney-Shea Herbert; Stephen F Konieczny; You-Yeon Won
Journal:  ACS Nano       Date:  2011-04-06       Impact factor: 15.881

5.  Charge shielding effects on gene delivery of polyethylenimine/DNA complexes: PEGylation and phospholipid coating.

Authors:  Xin Luo; Min Feng; Shirong Pan; Yuting Wen; Wei Zhang; Chuanbin Wu
Journal:  J Mater Sci Mater Med       Date:  2012-04-06       Impact factor: 3.896

6.  PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection.

Authors:  Forrest M Kievit; Omid Veiseh; Narayan Bhattarai; Chen Fang; Jonathan W Gunn; Donghoon Lee; Richard G Ellenbogen; James M Olson; Miqin Zhang
Journal:  Adv Funct Mater       Date:  2009-07-24       Impact factor: 18.808

7.  Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo.

Authors:  Christopher E Nelson; James R Kintzing; Ann Hanna; Joshua M Shannon; Mukesh K Gupta; Craig L Duvall
Journal:  ACS Nano       Date:  2013-09-23       Impact factor: 15.881

8.  Stability of poly(ethylene glycol)-graft-polyethylenimine copolymer/DNA complexes: influences of PEG molecular weight and PEGylation degree.

Authors:  Xin Luo; Shirong Pan; Min Feng; Yuting Wen; Wei Zhang
Journal:  J Mater Sci Mater Med       Date:  2009-10-17       Impact factor: 3.896

9.  PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.

Authors:  Saijie Zhu; Minghuang Hong; Lihong Zhang; Guotao Tang; Yanyan Jiang; Yuanying Pei
Journal:  Pharm Res       Date:  2009-10-28       Impact factor: 4.200

10.  Peptide-functionalized poly(ethylene glycol) star polymers: DNA delivery vehicles with multivalent molecular architecture.

Authors:  Katye M Fichter; Le Zhang; Kristi L Kiick; Theresa M Reineke
Journal:  Bioconjug Chem       Date:  2007-10-04       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.